Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis?

American Journal of Transplantation

Volumn 5, Issue 11, 2005, Pages 2796-2798

  Barcena, Rafael ^a   Oton, Elena ^a   Moreno, Maria Angeles ^a   Fortún, Jesús ^a   Garcia Gonzalez, Miguel ^a   Moreno, Ana ^a   De Vicente, Emilio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Infection; Liver failure; Liver transplantation; Toxicity

Indexed keywords

AMINOTRANSFERASE; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; EXTRAPULMONARY TUBERCULOSIS; HEPATITIS; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER NECROSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SIDE EFFECT; SKIN TEST; TUBERCULIN TEST; TUBERCULOUS SPONDYLITIS; CHEMICALLY INDUCED DISORDER; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; TUBERCULOSIS;

EID: 33644805478     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01065.x     Document Type: Article

References (13)

1. Dickinson DS Bailey WC Hirschowitz BI Soong SJ Eidus L Hodgkin MM. Risk factors for isoniazid (INH)-induced liver disfunction. J Clin Gastroenterol 1981 3: 271 279.
2. Garibaldi RA Drusin RE Ferebee SH Gregg MB. Isoniazid-associated hepatitis: report of an outbreak. Am Rev Respir Dis 1972 106: 357 365.
3. Mitchell JR Zimmerman HJ Ishak KG et al. Isoniazid liver injury: clinical spectrum pathology and probable pathogenesis. Ann Intern Med 1976 84: 181 192.
4. Sharer L Smith JP. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med 1969 71: 1113 1116.
5. Snider DE Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis 1992 145: 494 497.
6. Farrell FJ Keeffe EB Man KM Imperial JC Esquivel CO. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. Dig Dis Sci 1994 39: 2255 2259.
7. Meyers BR Halpern M Sheiner P et al. Acute hepatic failure in seven patients after prophylaxis and therapy with antituberculous agents. Successful treatment with orthotopic liver transplantation. Transplantation 1994 58: 372 377.
8. Aguado JM Herrero JA Gavalda J et al. Clinical presentation and outcome of tuberculosis in kidney, liver and heart transplant recipients in Spain. Transplantation 1997 63: 1278 1286.
9. Torre-Cisneros J Caston JJ Moreno J et al. Tuberculosis in the transplant candidate: importance of early diagnosis and treatment. Transplantation 2004 77: 1376 1380.
10. Meyers BR Papanicolaou GA Sheiner P Emre S Miller C. Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents: cure of disseminated infection with nonconventional regimens. Transplantation 2000 69: 64 69.
11. Blumberg HM Burman WJ Chaisson RE et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003 167: 603 662.
12. Huang YS Chern HD Su WJ et al. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology 2003 37: 924 930.
13. Huang YS Chern HD Su WJ et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 2002 35: 883 889.